Mr. Friedemann, you may proceed. Thank you very much, operator, and thank you all for joining our earnings call today. If you have not seen our earnings release, a copy is posted in the results center ...

As discussed during last quarter's earnings call, we amended this study's protocol to allow zaltenibart concentrations in patients to decrease until breakthrough hemolysis occurred, generating ...

The market is likely to rebound gradually, and a sustainable recovery will depend more on earnings growth rather than a sharp market correction, said Tata MF's Meeta Shetty.